Bacterial fermentation of recombinant major wasp allergen Antigen 5 using oxygen limiting growth conditions improves yield and quality of inclusion bodies.

A process for bacterial expression and purification of the recombinant major wasp allergen Antigen 5 (Ves v 5) was developed to produce protein for diagnostic and therapeutic applications for type 1 allergic diseases. Special attention was focused on medium selection, fermentation conditions, and efficient refolding procedures. A soy based medium was used for fermentation to avoid peptone from animal origin. Animal-derived peptone required the use of isopropyl-beta-D-thiogalactopyranoside (IPTG) for the induction of expression. In the case of soy peptone, a constitutive expression was observed, suggesting the presence of a component that mimics IPTG. Batch cultivation at reduced stirrer speed caused a reduced biomass due to oxygen limitation. However, subsequent purification and processing of inclusion bodies yielded significantly higher amount of product. Furthermore, the protein composition of the inclusion bodies differed. Inclusion bodies were denatured and subjected to diafiltration. Detailed monitoring of diafiltration enabled the determination of the transition point. Final purification was conducted using cation-exchange and size-exclusion chromatography. Purified recombinant Ves v 5 was analyzed by RP-HPLC, CD-spectroscopy, SDS-PAGE, and quantification ELISA. Up to 15 mg highly purified Ves v 5 per litre bioreactor volume were obtained, with endotoxin concentrations less than 20 EU mg(-1) protein and high comparability to the natural counterpart. Analytical results confirm the suitability of the recombinant protein for diagnostic and clinical applications. The results clearly demonstrate that not only biomass, but especially growth conditions play a key role in the production of recombinant Ves v 5. This has an influence on inclusion body formation, which in turn influences the renaturation rate and absolute product yield. This might also be true for other recombinant proteins that accumulate as inclusion bodies in Escherichia coli.

[1]  H. Fiebig,et al.  Rapid method for arrayed investigation of IgE‐reactivity profiles using natural and recombinant allergens , 2002, Allergy.

[2]  R. Van Ree,et al.  Cross‐reactivity of IgE antibodies to allergens , 2001, Allergy.

[3]  A. Kortt,et al.  Large-scale bacterial fermentation and isolation of scFv multimers using a heat-inducible bacterial expression vector. , 2002, Journal of immunological methods.

[4]  Kyoko Takahashi,et al.  Production of Enzymatically and Immunologically Active Der f 1 in Escherichia coli , 2000, International Archives of Allergy and Immunology.

[5]  J T Yang,et al.  Calculation of protein conformation from circular dichroism. , 1986, Methods in enzymology.

[6]  C. Ebner,et al.  Allergen‐specific immunosuppression by mucosal treatment with recombinant Ves v 5, a major allergen of Vespula vulgaris venom, in a murine model of wasp venom allergy , 2003, Immunology.

[7]  A. Kagey‐Sobotka,et al.  Recombinant Allergens with Reduced Allergenicity but Retaining Immunogenicity of the Natural Allergens: Hybrids of Yellow Jacket and Paper Wasp Venom Allergen Antigen 5s1 , 2001, The Journal of Immunology.

[8]  L. Goh,et al.  Soluble expression of a functionally active Plasmodium falciparum falcipain-2 fused to maltose-binding protein in Escherichia coli. , 2003, Protein expression and purification.

[9]  H. Fiebig,et al.  Purification and Immunobiochemical Characterization of Folding Variants of the Recombinant Major Wasp Allergen Ves v 5 (Antigen 5) , 2000, International Archives of Allergy and Immunology.

[10]  P. Righetti,et al.  Folding/unfolding/refolding of proteins: Present methodologies in comparison with capillary zone electrophoresis , 2001, Electrophoresis.

[11]  W. Keller,et al.  Circular dichroism analysis of allergens. , 2004, Methods.

[12]  T. Zollner,et al.  The Western blot is a highly sensitive and efficient technique in diagnosing allergy to wasp venom , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  F. Marston.  The purification of eukaryotic polypeptides synthesized in Escherichia coli. , 1986, The Biochemical journal.

[14]  P. Schmid‐Grendelmeier,et al.  Recombinant Allergens for Skin Testing , 2001, International Archives of Allergy and Immunology.

[15]  L. Lichtenstein,et al.  Protein allergens of white-faced hornet, yellow hornet, and yellow jacket venoms. , 1978, Biochemistry.

[16]  X. Ji,et al.  Expression of soluble, biologically active recombinant human endostatin in Escherichia coli. , 2005, Protein expression and purification.

[17]  P. Bhalla,et al.  Engineered allergens for immunotherapy , 2004, Current opinion in allergy and clinical immunology.

[18]  H. Malandain.  IgE-reactive carbohydrate epitopes--classification, cross-reactivity, and clinical impact (2nd part). , 2005, European annals of allergy and clinical immunology.

[19]  T. P. King,et al.  Expressions of recombinant venom allergen, antigen 5 of yellowjacket (Vespula vulgaris) and paper wasp (Polistes annularis), in bacteria or yeast. , 1999, Protein expression and purification.

[20]  E Habermann,et al.  Bee and wasp venoms. , 1972, Science.

[21]  Wayne Thomas,et al.  Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  R. Valenta,et al.  From allergen structure to new forms of allergen-specific immunotherapy. , 2002, Current opinion in immunology.

[23]  T. P. King,et al.  Structure and Biology of Stinging Insect Venom Allergens , 2000, International Archives of Allergy and Immunology.

[24]  C. Shone,et al.  Isolation of the gene and large-scale expression and purification of recombinant Erythrina cristagalli lectin. , 2003, Protein expression and purification.

[25]  Niederberger,et al.  The recombinant allergen‐based concept of component‐resolved diagnostics and immunotherapy (CRD and CRIT) , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.